One potential explanation for the heightened CXCL9 response to IFNγ in MIS-C patients is lower levels of TRIM21, a protein notable for its ability to repress IFNγ signaling through degradation of interferon response factors34,35. Here, IFNG is linked to COVID-19–associated multisystem inflammatory syndrome in children.